4 Oncology Stocks To Consider As Biotech Companies Escalate Their Fight Against Cancer
Examining four oncology stocks that could be smart picks right now.
Examining four oncology stocks that could be smart picks right now.
After trailing the broader market for the past few months, biotech has gotten some love in recent days – from the FDA in the form of its approval of Biogen’s controversial Alzheimer’s drug, and also from the Reddit crowd.
Mental health issues are on the rise – and so is demand for treatments for mental health disorders based on psychedelic substances.
As PDUFA dates can serve as catalysts for stocks, biotech investors can be well served by paying attention to them.
What do these impending decisions mean for healthcare and biotech stocks?
A year or so ago, the gene therapy trend was hot – until it quickly cooled down. But now may be the time to get back in on this trend, especially with one particular biotech stock.
The biotech featured in today’s article “selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a significant benefit over existing products.”
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the slew of new biotech stocks to watch.
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the slew of new biotech stocks to watch.
“When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.”